212 related articles for article (PubMed ID: 8898378)
1. A novel protease homolog differentially expressed in breast and ovarian cancer.
Anisowicz A; Sotiropoulou G; Stenman G; Mok SC; Sager R
Mol Med; 1996 Sep; 2(5):624-36. PubMed ID: 8898378
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression.
Liu XL; Wazer DE; Watanabe K; Band V
Cancer Res; 1996 Jul; 56(14):3371-9. PubMed ID: 8764136
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of protease M in ovarian tumors.
Tanimoto H; Underwood LJ; Shigemasa K; Parmley TH; O'Brien TJ
Tumour Biol; 2001; 22(1):11-8. PubMed ID: 11054022
[TBL] [Abstract][Full Text] [Related]
4. The kallikrein gene 5 splice variant 2 is a new biomarker for breast and ovarian cancer.
Yousef GM; White NM; Kurlender L; Michael I; Memari N; Robb JD; Katsaros D; Stephan C; Jung K; Diamandis EP
Tumour Biol; 2004; 25(5-6):221-7. PubMed ID: 15627884
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression.
Nelson PS; Gan L; Ferguson C; Moss P; Gelinas R; Hood L; Wang K
Proc Natl Acad Sci U S A; 1999 Mar; 96(6):3114-9. PubMed ID: 10077646
[TBL] [Abstract][Full Text] [Related]
6. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
[TBL] [Abstract][Full Text] [Related]
7. Sequencing and expression analysis of the serine protease gene cluster located in chromosome 19q13 region.
Gan L; Lee I; Smith R; Argonza-Barrett R; Lei H; McCuaig J; Moss P; Paeper B; Wang K
Gene; 2000 Oct; 257(1):119-30. PubMed ID: 11054574
[TBL] [Abstract][Full Text] [Related]
8. Human kallikrein 5: a potential novel serum biomarker for breast and ovarian cancer.
Yousef GM; Polymeris ME; Grass L; Soosaipillai A; Chan PC; Scorilas A; Borgoño C; Harbeck N; Schmalfeldt B; Dorn J; Schmitt M; Diamandis EP
Cancer Res; 2003 Jul; 63(14):3958-65. PubMed ID: 12873991
[TBL] [Abstract][Full Text] [Related]
9. KLK12 is a novel serine protease and a new member of the human kallikrein gene family-differential expression in breast cancer.
Yousef GM; Magklara A; Diamandis EP
Genomics; 2000 Nov; 69(3):331-41. PubMed ID: 11056051
[TBL] [Abstract][Full Text] [Related]
10. Cloning of tumor-associated differentially expressed gene-14, a novel serine protease overexpressed by ovarian carcinoma.
Underwood LJ; Tanimoto H; Wang Y; Shigemasa K; Parmley TH; O'Brien TJ
Cancer Res; 1999 Sep; 59(17):4435-9. PubMed ID: 10485494
[TBL] [Abstract][Full Text] [Related]
11. Expression of the protease inhibitor antileukoprotease and the serine protease stratum corneum chymotryptic enzyme (SCCE) is coordinated in ovarian tumors.
Shigemasa K; Tanimoto H; Underwood LJ; Parmley TH; Arihiro K; Ohama K; O'Brien TJ
Int J Gynecol Cancer; 2001; 11(6):454-61. PubMed ID: 11906548
[TBL] [Abstract][Full Text] [Related]
12. Genomic organization, mapping, tissue expression, and hormonal regulation of trypsin-like serine protease (TLSP PRSS20), a new member of the human kallikrein gene family.
Yousef GM; Scorilas A; Diamandis EP
Genomics; 2000 Jan; 63(1):88-96. PubMed ID: 10662548
[TBL] [Abstract][Full Text] [Related]
13. Prostase/KLK-L1 is a new member of the human kallikrein gene family, is expressed in prostate and breast tissues, and is hormonally regulated.
Yousef GM; Obiezu CV; Luo LY; Black MH; Diamandis EP
Cancer Res; 1999 Sep; 59(17):4252-6. PubMed ID: 10485467
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of an epithelial-specific receptor tyrosine kinase from an ovarian cancer cell line.
Laval S; Butler R; Shelling AN; Hanby AM; Poulsom R; Ganesan TS
Cell Growth Differ; 1994 Nov; 5(11):1173-83. PubMed ID: 7848919
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP
Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462
[TBL] [Abstract][Full Text] [Related]
16. Identification and functional characterization of a human GalNAc [alpha]2,6-sialyltransferase with altered expression in breast cancer.
Sotiropoulou G; Kono M; Anisowicz A; Stenman G; Tsuji S; Sager R
Mol Med; 2002 Jan; 8(1):42-55. PubMed ID: 11984005
[TBL] [Abstract][Full Text] [Related]
17. Ovarian tumor cells express a transmembrane serine protease: a potential candidate for early diagnosis and therapeutic intervention.
Tanimoto H; Underwood LJ; Wang Y; Shigemasa K; Parmley TH; O'Brien TJ
Tumour Biol; 2001; 22(2):104-14. PubMed ID: 11125283
[TBL] [Abstract][Full Text] [Related]
18. Cloning of hHRI, human heme-regulated eukaryotic initiation factor 2alpha kinase: down-regulated in epithelial ovarian cancers.
Hwang SY; Kim MK; Kim JC
Mol Cells; 2000 Oct; 10(5):584-91. PubMed ID: 11101152
[TBL] [Abstract][Full Text] [Related]
19. Identification of a novel aspartic-like protease differentially expressed in human breast cancer cell lines.
Xin H; Stephans JC; Duan X; Harrowe G; Kim E; Grieshammer U; Kingsley C; Giese K
Biochim Biophys Acta; 2000 Jun; 1501(2-3):125-37. PubMed ID: 10838186
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
Shvartsman HS; Lu KH; Lee J; Lillie J; Deavers MT; Clifford S; Wolf JK; Mills GB; Bast RC; Gershenson DM; Schmandt R
Gynecol Oncol; 2003 Jul; 90(1):44-50. PubMed ID: 12821340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
